Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Grifols S.A.
DescriptionHuman intravenous immunoglobulin (IVIg) 5% DIF
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II/III
Standard Indication Neurology (unspecified)
Indication DetailsTreat post-polio syndrome
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today